Singapore’s vision is to be leading manufacturing hub: Iswaran

Singapore’s vision is to be a leading manufacturing hub, plugged into global centres of excellence to drive the future of manufacturing, asserted S Iswaran, Minister for Trade and Industry (Industry) of Singapore while speaking at Future of Manufacturing (FoM) Summit today.

He said, “The Government is committed to supporting the development of advanced manufacturing technologies in Singapore to ensure the continued competitiveness of our manufacturing sector.”

S Iswaran, Minister for Trade and Industry (Industry) of Singapore
S Iswaran, Minister for Trade and Industry (Industry) of Singapore. Photo courtesy: Youtube

While informing the audience about the five-year Research, Innovation and Enterprise 2020 plan (RIE2020), the Minister said, “SGD3.2 billion has been committed for the Advanced Manufacturing and Engineering (AME) domain, to support the development of technological capabilities in the manufacturing and engineering sectors. This includes cross-cutting technologies such as digital manufacturing, robotics and automation, and additive manufacturing.”

He said, “Our efforts will build on the strong partnerships which we have established over the years with global industry leaders.  This will ensure that Singapore continues to be plugged into the centres of excellence around the world, particularly in our key manufacturing verticals.”

On the occasion, The Agency for Science, Technology and Research (A*STAR), National University of Singapore (NUS) and three pharmaceutical companies also inked a Memorandum of Understanding to mark the launch of an initiative to develop the country's pharma manufacturing sector. 

The initiative, christened the Pharma Innovation Programme Singapore (PIPS) invloves GSK, Pfizer and MSD. 

The main aim of the PIPS is to transform the manufacturing operations and technologies of the pharma industry. This includes enabling green and sustainable manufacturing through the use of bio-catalysis technologies, as well as developing a fully-automated supply chain that can predict and react to patient demands and market trends.

While speaking about the MOU, Iswaran said, “It is important to strengthen partnerships within the local manufacturing sector to pool resources. PIPS combines the research capabilities of the public sector with the expertise of private pharma companies.”

Author
Ashraf Jamal
Ashraf Jamal – Senior Writer

Ashraf Jamal brings a rare depth to writing equipped with a degree in journalism, a postgraduate degree in political science, and a degree in law from the Allahabad University. His experience includes editing and publishing the Northern India Patrika and writing for Times of India for almost a decade covering just about any topic under the sun including NRIs and Indian diaspora.

Comments